Photopheresis System
The latest therapeutic platform from our representative manufacturer is the world's only validated and fully integrated system for immune cell therapy using extracorporeal photopheresis (ECP). These systems are used by hospitals, medical research and treatment centres in more than 30 countries worldwide. To date, more than one million procedures have been performed using this therapy.
Sterile (metoxalen) solution is prescribed for extracorporeal administration together with or Photopheresis System during palliative treatment of cutaneous T-cells lymphoma manifestations when other treatment methods are not effective.
Want to know more?
System is a photosynthesis platform of new generation connecting modern technologies of cell selection (separation), photo activation and reinfusion into one closed integrated system The structure of an integrated closed system allows one operator managing a photopheresis process and reducing risks of infections, cross-contamination and patient’s repeated infection. Besides, system reduce treatment duration twice from 3 h down to 1.5 h.
Functions of system are designed by taking responses of clinicians into consideration:
- Advanced, single-harvest centrifuge design with continuous separation;
- Flexible treatment options, including customized fluid management and single- or double-needle mode, for varying patient needs. Double-needle mode further reduces treatment time by about 30 minutes;
- Patented algorithm automates cell collection and optimizes UVA activation of cell product;
- Single use, sterile Procedural Kit for easy set up and minimal waste;
- Highly visible, multilingual interactive display enhances operation and training;
- Automated sensors and flow rate to optimize collection photoactivation time;
- Automated safety features, including air emboli detector, audible alarms and message display for specific alarm status, and for line occlusion of each fluid line.